GARFIELD-VTE exploring acute and long-term management and outcomes in patients with symptomatic DVTs and PEs treated in a real-world setting with standard therapy and new oral anticoagulants (OACs)
Recruitment – complete
Total Patients Enrolled – 10,878
GARFIELD-VTE exploring acute and long-term management and outcomes in patients with symptomatic DVT and PEs treated in a real world setting with standard therapy and new oral anticoagulants (OACs). It will provide patients, physicians and policy makers with unprecedented insights on managing and improvement patient care. For patients with DVT and PE, fast action in the acute phase of treatment, especially rapidly fatal PEs, is vital for preserving life and health. Equally important, the risk of recurrence needs to also be managed. Current treatment regimens in real-life practice seem to be shorter than recommended guidelines. Real – world clinical data is needed to confirm this dynamic and understand why it occurs. The GARFIELD registry is an academic research initiative, led by the TRI and a multi-disciplinary steering committee – and it is supported by an unrestricted research grant from Bayer AG. The Global Anticoagulant Registry in the field of venous thromboembolism events is a perspective, multicentre, international registry of patients with newly diagnosed VTE: Deep Vein Thrombosis (DVT) and / or Pulmonary Embolism (PE). The GARFIELD-VTE registry will bring a real-world perspective to the field of venous thrombosis.
Scroll over the window below to view our timeline
GARFIELD-VTE is important in bridging the gap between research and clinical practice, serving to increase awareness of the importance of DVT / PE and its treatment.
The objectives are:
Over the duration of the registry GARFIELD-VTE will:
Obtain clarity on:
Additional outcomes include:
GARFIELD-VTE is governed by the highest academic and ethical standards in the generation, dissemination and communication of its research findings.
GARFIELD-VTE exploring acute and long-term management and outcomes in patients with symptomatic... [read more]
The Steering Committee, supported by the National Coordinator Council, provides global leadership... [read more]
Coming soon… If you would like to be notified of when this is available click here and add your details to receive updates